Article
Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
Clinical therapeutics - 1 Nov 2009
Cho Hea-Young, Yoon Hwa, Park Geun-Kyeong, Lee Yong-Bok
Abstract excerpt
BACKGROUND: Rebamipide is a quinolinone-derived gastroprotective agent approved in Korea for the treatment of gastric ulcers, acute gastritis, and exacerbated chronic gastritis. OBJECTIVES: The aims of this study were to evaluate the pharmacokinetics and bioequivalence of a reference (branded) an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
